Financhill
Back

OptimizeRx Quote, Financials, Valuation and Earnings

OptimizeRx Price Quote

$4.90
+0.01 (+3.16%)
(Updated: December 21, 2024 at 5:40 AM ET)

OptimizeRx Key Stats

Sell
19
OptimizeRx (OPRX) is a Sell

Day range:
$4.62 - $5.06
52-week range:
$3.78 - $16.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.01
P/B ratio:
0.79%

Volume:
290.3K
Avg. volume:
410.1K
1-year change:
-65.15%
Market cap:
$90.1M
Revenue:
$71.5M
EPS:
$-1.34

How Much Does OptimizeRx Make?

Data Unavailable

Is OptimizeRx Growing As A Company?

Data Unavailable

OptimizeRx Stock Price Performance

  • Did OptimizeRx Stock Go Up Last Month?
    OptimizeRx share price went up by 10.63% last month
  • Did OPRX's Share Price Rise Over The Last Year?
    OPRX share price fell by -65.15% over the past 1 year

What Is OptimizeRx 52-Week High & Low?

  • What Is OptimizeRx’s 52-Week High Share Price?
    OptimizeRx has traded as high as $16.65 over the past 52 weeks
  • What Is OptimizeRx’s 52-Week Low Share Price?
    OptimizeRx has traded as low as $3.78 over the past 52 weeks

OptimizeRx Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy OptimizeRx?

Data Unavailable

Is OptimizeRx Cash Flow Positive?

Data Unavailable

OptimizeRx Return On Invested Capital

Data Unavailable

OptimizeRx Earnings Date & Stock Price

  • What Is OptimizeRx's Stock Price Today?
    A single share of OPRX can be purchased today for 4.89
  • What Is OptimizeRx’s Stock Symbol?
    OptimizeRx trades on the nasdaq under the ticker symbol: OPRX
  • When Is OptimizeRx’s Next Earnings Date?
    The next quarterly earnings date for OptimizeRx is scheduled on March 28, 2025
  • When Is OPRX's next ex-dividend date?
    OptimizeRx's next ex-dividend date is May 21, 2020
  • How To Buy OptimizeRx Stock?
    You can buy OptimizeRx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

OptimizeRx Competitors

  • Who Are OptimizeRx's Competitors?
    Below is a list of companies who compete with OptimizeRx or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Amedisys Inc (AMED)
    • Health Catalyst Inc (HCAT)
    • Option Care Health Inc (OPCH)
    • Regional Health Properties Inc (RHE)

OptimizeRx Dividend Yield

Data Unavailable

OptimizeRx Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 103.39%
Revenue: 30.48% -14.75%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.36
Upside from Last Price: 111.8%

Major Shareholders

Data Unavailable